Drug Target Review

FEBRUARY 19, 2024

I always found science fascinating, but I really fell in love with it in high school when I was introduced to biochemistry and molecular biology. Biochemistry and molecular biology fascinated me in school. I am proud to have contributed to the advancements in monoclonal antibody discovery and development.

Molecular Biology 110

Molecular Biology Science Protein Expression Production 110

Drug Target Review

SEPTEMBER 22, 2023

5 Organoids are recognised as New Alternative Methods (NAMs) in drug development. This recognition was codified by the United States Food and Drug Administration (FDA) in 2022 with the signing of the FDA Modernisation Act 2.0 This can aid in the development of safer, more effective therapeutic strategies. Front Genet.

Clinical Research 116

Clinical Research Research Drug Development Molecular Biology 116

Drug Target Review

MARCH 15, 2024

Transposon technologies are gaining traction due to their accuracy in integrating the gene of interest into the host genome, making them an important tool for accelerating large molecule drug development. Anis also serves on the scientific and editorial advisory board of Genetic Engineering News at Mary Ann Liebert, Inc.

Engineering 105

Engineering Molecular Biology Protein Expression Medical Schools 105

BMG Labtech

MARCH 11, 2024

This is reflected in scientific discoveries across many research disciplines including immunology , molecular biology , medicine, and diagnostics. Specific areas where they have had a wide impact include virology , bacteriology, biotechnology , fungal biology, cancer and oncology (e.g.

Vaccine 98

Vaccine Molecular Biology Laboratories Virus 98

The Pharma Data

FEBRUARY 25, 2022

. “The SARS-CoV-2 vaccines target the spike protein, but this protein is under strong selection pressure and, as we have seen with Omicron, can undergo significant mutations,” said Joyce Jose, assistant professor of biochemistry and molecular biology, Penn State. 25) in the journal Communications Biology.

FDA Approval 52

FDA Approval Molecular Biology FDA Virus 52

Drug Target Review

MAY 27, 2024

We feel that target discovery is the gatekeeper to successful drug development and can maximize our probability of success through diversified and thoughtful partnerships with biopharma. We are excited about our recently announced partnership with Merck KGaA, Darmstadt, Germany to discover and validate novel ADC targets.

Clinical Trials 59

Clinical Trials Science Molecular Biology Bioinformatics 59

Alta Sciences

JUNE 11, 2024

One thing is for sure—regardless of how the field evolves around regulation requirements, Altasciences has the experience and range of capabilities to take on your gene therapy drug development programs. Connect with Dr. Turcotte on LinkedIn. Image Thumbnail_Blog_June 2024.jpg

Therapies 52

Therapies Molecular Biology Immune Response Science 52

Drug Target Review

OCTOBER 3, 2024

In 2024 alone, almost 50 antibody drug candidates are anticipated to enter regulatory review, the majority of which are mAbs. Aside from the advent of complex antibody-based drugs, the industry is facing some additional changes which are shaping drug development. Methods in Molecular Biology. 2021;291–306.

Molecular Biology 52

Molecular Biology Pharmacokinetics Laboratories Animal Testing 52

Elrig

APRIL 29, 2024

She is involved in the research and development of cellular assays across multiple research areas for live-cell analysis applications, including AI-based image analysis tools. You’ll also need to understand machine learning, which is a big part of using artificial intelligence in drug discovery.

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

Drug Target Review

JUNE 19, 2024

From 1999 until 2000, he worked at the University of California, San Diego (UCSD) Department of Technology Transfer & Intellectual Property Services and from 1996 to 1999 he conducted drug development research for Neurocrine Biosciences, Inc. Mr Culley served on the Board of Orphagen Pharmaceuticals, Inc.

Therapies 84

Therapies Small Molecule Pharmaceutical Companies Molecular Biology 84

Vial

MARCH 1, 2024

Leading Global CROs To advance new therapies, pharma, biotech, and medical device sponsors engage CROs to help navigate the complex landscape of drug development and regulatory pathways and to manage clinical trials efficiently, ethically, and in compliance with good clinical practice ( GCP ) standards. of total revenue).

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

The Pharma Data

JANUARY 6, 2021

The approach used to turn botulinum toxin into a kind of Trojan horse that delivers a cargo into neurons has enormous potential for future drug development,” noted Thomas C. “This is a landmark study in converting the power of lethal botulinum neurotoxins into therapies. Südhof, M.D.,

Science 52

Science Molecular Biology Treatment Production 52

Drug Target Review

OCTOBER 25, 2024

The Role of Biomarkers in Alzheimer’s Disease Drug Development. Progress in molecular biology and translational science. A how-to guide for a precision medicine approach to the diagnosis and treatment of alzheimer’s disease. link] Cummings J. Adv Exp Med Biol. 2019;1118:29-61. doi: 10.1007/978-3-030-05542-4_2.

Disease 59

Disease Clinical Trials Therapies Science 59

Alta Sciences

AUGUST 21, 2024

Internships at Altasciences: Q&A With Our Summer Interns nbartlett Thu, 08/22/2024 - 04:44 Internships at Altasciences are more than just a stepping stone—they’re a gateway to real-world-experience and professional growth, giving the next generation opportunities to help shape progress in the drug development industry.

International 40

International Laboratories Science Molecular Biology 40

The Pharma Data

JANUARY 4, 2021

Longwood has a robust research department with 7 post doctorates conducting research in molecular biology, microbiology, genomics, cancer biology, and immunology and publishing over 75 publications in different scientific journals in the past 5 years. Barber also serves on Kiromic’s Scientific Advisory Board.

Therapies 40

Therapies Molecular Biology Immune Response Science 40

Codon

FEBRUARY 13, 2024

Because frankly, do you know of anything else that can work against multiple drug-resistant bacteria? ” A Global View Even as advances in computing and molecular biology usher in the era of a new, high-tech “phage therapy 2.0”,

Therapies 125

Therapies Virus DNA Clinical Trials 125

The Pharma Data

JANUARY 25, 2021

With a background in molecular biology and clinical chemistry, Dr. Zetterberg has spent the last 20 years focusing on the development of biomarkers for Alzheimer’s disease, Parkinson’s disease and other brain disorders.

Disease 40

Disease Clinical Development Molecular Biology Treatment 40

Drug Target Review

FEBRUARY 15, 2024

Advances in molecular biology have led to highly safe, efficient, and effective platforms, such as mRNA, that can be rapidly re-purposed for different pathogens, multiple pathogens, or new strains of evolving pathogens.

Drug Development 122

Drug Development Virus Vaccine Government 122

Drug Target Review

FEBRUARY 19, 2025

His areas of expertise include biologic drug development, cell and gene therapies, and gene editing. Cedrone holds a PhD in molecular biology and enzyme engineering from Marseille University, France.

Therapies 59

Therapies Molecular Biology Regulations Packaging 59